Skip to main content
    G

    GSK plc (GSK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $49.23
    -1.18 (-2.35%)

    Market Cap: $101.13B

    Last updated: Nov 17, 2026 at 4:25 PM ET

    GSK plc (GSK) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    GSK has a market cap of $101.13B. Its trailing P/E is 10.3x.

    Total Valuation

    Market Cap$101.13B
    Latest price (Nov 17, 2026)$49.23

    Key Dates

    The last ex-dividend date was Nov 13, 2026.

    Last Earnings DateOct 28, 2026
    Last Ex-Dividend DateNov 13, 2026
    Next Payment DateJan 7, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.27% in the quarter ended Sep 30, 2026 and shrank 0.09% a year over 2 years.

    Shares Outstanding2.04B
    Shares Change (YoY)-0.71%
    Shares Change (QoQ)+0.27%
    Share Count Growth (2Y CAGR)-0.09%

    Valuation Ratios

    Sales and book value multiples are 2.3x and 4.0x.

    P/E Ratio10.3x
    P/S Ratio2.3x
    P/B Ratio4.0x
    P/FCF Ratio11.1x
    PEG Ratio2.2

    Valuation history and multiples

    Price Statistics

    The stock is up 5.19% over 52 weeks and trades 0.65% above its 50-day average.

    Beta (1Y)0.28
    52-Week Change+5.19%
    1-Month Change+0.42%
    3-Month Change-6.08%
    6-Month Change-2.70%
    5-Year Change-6.43%
    10-Year Change-1.00%
    Total Return (1Y)+9.14%
    Total Return (3Y CAGR)+14.53%
    Total Return (5Y CAGR)+2.08%
    Return vs SPY (1Y)-6.80%
    Max Drawdown (1Y)-23.82%
    Max Drawdown (3Y)-28.45%
    Sharpe Ratio (1Y)0.18
    Correlation with SPY (1Y)0.15
    50-Day Average$48.91
    200-Day Average$51.72
    52-Week Range$44.23 to $59.57
    RSI (14 Days)48.0
    Average Volume (20 Days)3.77M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.86x current liabilities.

    Current Ratio0.86x
    Quick Ratio0.56x
    Interest Coverage8.80x

    Returns and Efficiency

    Return on equity is 23.00% over the last 12 months, against a 5-year average of 50.66%.

    Return on Equity (ROE)23.00%
    Return on Assets (ROA)6.02%
    Return on Capital Employed (ROCE)12.70%
    ROE (5Y Average)50.66%
    ROA (5Y Average)10.20%
    ROIC (5Y Average)14.52%
    Asset Turnover0.43x
    Inventory Turnover1.44x
    Receivables Turnover4.04x
    Cash Conversion Cycle-259 days

    Taxes

    Income tax took 10.42% of pretax income over the last 12 months.

    Income Tax (TTM)GBP 559.17M
    Effective Tax Rate10.42%

    Scores

    GSK has an Altman Z-Score of 1.80, in the distress zone below 1.81, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.

    Altman Z-Score1.80
    Altman Z ZoneDistress
    Piotroski F-Score9 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of GBP 33.47B over the last 12 months is up 4.06% from the 12 months before.

    RevenueGBP 33.47B
    Revenue Growth (YoY)+4.06%
    Gross ProfitGBP 24.42B
    Operating IncomeGBP 6.83B
    Pretax IncomeGBP 5.37B
    Net IncomeGBP 4.34B
    EBITDAGBP 8.73B
    EBITGBP 6.52B

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 26.16% of the GBP 72.18B in total assets.

    Working CapitalGBP -2.84B
    Shareholder EquityGBP 18.88B
    Tangible Book ValueGBP -14.73B
    Total AssetsGBP 72.18B
    Total LiabilitiesGBP 53.69B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After GBP 1.70B of capital spending, operating cash flow left GBP 6.79B of free cash flow.

    Operating Cash FlowGBP 8.50B
    Capital ExpendituresGBP 1.70B
    Free Cash FlowGBP 6.79B
    Depreciation and AmortizationGBP 2.21B
    Dividends PaidGBP 2.68B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 20.40%, against a 5-year average of 19.78%.

    Gross Margin72.96%
    Operating Margin20.40%
    Pretax Margin16.04%
    Net Margin12.96%
    EBITDA Margin26.07%
    EBIT Margin19.48%
    FCF Margin20.30%
    Gross Margin (5Y Average)69.94%
    Operating Margin (5Y Average)19.78%
    Net Margin (5Y Average)22.14%

    Growth

    Revenue grew 3.66% a year over 3 years.

    Revenue Growth (3Y CAGR)+3.66%
    Revenue Growth (5Y CAGR)+6.05%
    FCF Growth (3Y CAGR)+7.51%
    FCF Growth (5Y CAGR)+0.61%
    Operating Income Growth (3Y CAGR)+7.23%

    Revenue and profit by year

    Dividends and Yields

    GSK pays out 33.31% of earnings as dividends.

    Dividend Per Share (Annual)$1.81
    Dividend Yield3.67%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-4.40%
    Dividend Growth (5Y CAGR)-9.01%
    Payout Ratio33.31%
    FCF Payout Ratio39.44%
    Earnings Yield9.71%
    FCF Yield9.02%

    Full dividend history

    Stock Splits

    The last reverse split was on Jul 19, 2022.

    Last Split DateJul 19, 2022
    Split TypeReverse split

    Peer Position

    Against 9 similar companies, GSK has the 7th highest P/E.

    P/E Ratio10.3x vs 19.8x median
    P/S Ratio2.3x vs 4.1x median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.06% vs +5.31% median
    Dividend Yield3.67% vs 2.37% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GSK

    What is GSK's market cap?

    GSK has a market cap of $101.13B.

    What is GSK's P/E ratio?

    GSK has a trailing P/E ratio of 10.3x.

    How many shares of GSK are outstanding?

    GSK has 2.04B shares outstanding. The count is down 0.71% from a year earlier.

    Does GSK pay a dividend?

    Yes. GSK pays $1.81 a share a year, a dividend yield of 3.67%.